Evidence map›Paper›PMID 36383617›Full record

ArticlePLoS neglected tropical diseases2022

Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala.

Alejandra Paniagua-Avila, Daniel Olson, Amy Connery, D Mirella Calvimontes, Guillermo A Bolanos, Molly M Lamb, Desiree Bauer, Aida Ralda, Neudy Rojop, Eduardo Barrios and 15 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Future Goals and Long-term Vision of the Infectious Diseases Clinical Research Consortium/Vaccine and Treatment Evaluation Unit Network.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Alejandra Paniagua-AvilaCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Daniel OlsonCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.ORCID 0000-0002-2374-1448
Amy ConneryCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
D Mirella CalvimontesCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Guillermo A BolanosCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Molly M LambDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, United States of America.
Desiree BauerCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Aida RaldaCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Neudy RojopCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Eduardo BarriosCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Andrea ChaconCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Melissa GomezCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Paola ArroyaveCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Sara HernandezCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Maria Alejandra MartinezCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Saskia Bunge-MontesCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Alison ColbertDepartment of Rehabilitation Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Kareen AriasCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Garret BrazealeCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Andrea HollidayEmmes Company, LLC, Rockville, Maryland, United States of America.
Kay M TomashekEmmes Company, LLC, Rockville, Maryland, United States of America.
Hana M El SahlyDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Wendy KeitelDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Flor M MunozDepartment of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0002-0457-7689
Edwin J AsturiasCenter for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.ORCID 0000-0002-1275-0787
Columbia University · USBaylor College of Medicine · USColorado School of Public Health · USEmmes (United States) · USUniversity of Colorado Denver · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Predictors of Influenza-Associated Absenteeism and Impact of Vaccination in a Cohort of Guatemalan Agricultural WorkersK23AI143967 · NIAID · UNIVERSITY OF COLORADO DENVER · PI OLSON, DANIEL · 2019 to 2023
$1.2M
NCRR NIH HHS UL1 RR025780NIAID NIH HHS HHSN272201300015CNIAID NIH HHS HHSN272201300015INIAID NIH HHS K23 AI143967
6 · The paper itself

Abstract

During the course of the 2015-2017 outbreak of Zika virus (ZIKV) in the Americas, the emerging virus was recognized as a congenital infection that could damage the developing brain. As the Latin American ZIKV outbreak advanced, the scientific and public health community questioned if this newly recognized neurotropic flavivirus could affect the developing brain of infants and young children infected after birth. We report here the study design, methods and the challenges and lessons learned from the rapid operationalization of a prospective natural history cohort study aimed at evaluating the potential neurological and neurodevelopmental effects of postnatal ZIKV infection in infants and young children, which had become epidemic in Central America. This study enrolled a cohort of 500 mothers and their infants, along with nearly 400 children 1.5-3.5 years of age who were born during the initial phase of the ZIKV epidemic in a rural area of Guatemala. Our solutions and lessons learned while tackling real-life challenges may serve as a guide to other researchers carrying out studies of emerging infectious diseases of public health priority in resource-constrained settings.

Indexed as

Pregnancy Complications, InfectiousZika VirusZika Virus InfectionChildChild, PreschoolCohort StudiesFemaleGuatemalaHumansInfantPregnancyProspective Studies

Identifiers

PMID36383617
PMCPMC9710790
OpenAlexW4309135017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.